Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where BMED declined for three days, in 216 of 279 cases, the price declined further within the following month. The odds of a continued downward trend are 77%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on BMED as a result. In 69 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for BMED just turned positive on October 15, 2026. Looking at past instances where BMED's MACD turned positive, the stock continued to rise in 33 of 45 cases over the following month. The odds of a continued upward trend are 73%.
Following a +3.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMED advanced for three days, in 226 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The 10-day moving average for XLV crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on XLV as a result. In 80 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for XLV just turned positive on October 09, 2026. Looking at past instances where XLV's MACD turned positive, the stock continued to rise in 36 of 49 cases over the following month. The odds of a continued upward trend are 73%.
XLV moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where XLV advanced for three days, in 265 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Aroon Indicator entered an Uptrend today. In 230 of 271 cases where XLV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.
The 10-day RSI Indicator for XLV moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 31 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 82%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
XLV broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
| BMED | XLV | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 82% |
| Stochastic ODDS (%) | 2 days ago 74% | 2 days ago 80% |
| Momentum ODDS (%) | 2 days ago 73% | 2 days ago 82% |
| MACD ODDS (%) | 2 days ago 73% | 2 days ago 73% |
| TrendWeek ODDS (%) | 2 days ago 78% | 2 days ago 82% |
| TrendMonth ODDS (%) | 2 days ago 80% | 2 days ago 84% |
| Advances ODDS (%) | 3 days ago 81% | 3 days ago 81% |
| Declines ODDS (%) | 5 days ago 77% | 16 days ago 82% |
| BollingerBands ODDS (%) | N/A | 2 days ago 88% |
| Aroon ODDS (%) | N/A | 2 days ago 85% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| STOT | 46.31 | 0.03 | +0.05% |
| State Street DoubleLine Short Duration Total Return Tactical ETF (STOT) | |||
| CPSD | 27.23 | N/A | N/A |
| Calamos S&P 500 Structured Alt Protection ETF - December (CPSD) | |||
| ENDW | 34.53 | -0.07 | -0.21% |
| Cambria Endowment Style ETF (ENDW) | |||
| MCDS | 66.09 | -0.52 | -0.78% |
| JPMorgan Fundamental Data Science Mid Core ETF (MCDS) | |||
| AAXJ | 108.12 | -2.24 | -2.03% |
| iShares MSCI All Country Asia ex Japan ETF (AAXJ) | |||
A.I.dvisor tells us that BMED and BRKR have been poorly correlated (+19% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMED and BRKR's prices will move in lockstep.
| Ticker / NAME | Correlation To BMED | 1D Price Change % | ||
|---|---|---|---|---|
| BMED | 100% | -1.45% | ||
| BRKR - BMED | 19% Poorly correlated | -3.08% | ||
| MCRB - BMED | 13% Poorly correlated | -2.77% | ||
| ILMN - BMED | 13% Poorly correlated | -2.01% | ||
| BDX - BMED | 12% Poorly correlated | -1.04% | ||
| CNMD - BMED | 11% Poorly correlated | -0.89% | ||
More | ||||
A.I.dvisor indicates that over the last year, XLV has been closely correlated with LLY. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if XLV jumps, then LLY could also see price increases.